Open AccessStatin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary Fibrosis
Author(s) -
Michael Kreuter,
Ulrich Costabel,
Luca Richeldi,
Vincent Cottin,
Marlies Wijsenbeek,
Francesco Bonella,
Elisabeth Bendstrup,
Toby M. Maher,
Daniel Wachtlin,
Susanne Stowasser,
Martin Kolb
Publication year - 2018
Publication title -
respiration
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.264
H-Index - 81
eISSN - 1423-0356
pISSN - 0025-7931
DOI - 10.1159/000486286
Subject(s) - medicine , nintedanib , idiopathic pulmonary fibrosis , placebo , statin , clinical trial , gastroenterology , lung , pathology , alternative medicine
Cardiovascular comorbidities are frequent in patients with idiopathic pulmonary fibrosis (IPF), and many patients with IPF receive treatment with statins to reduce cardiovascular risk.